A part of Watch Medier Senior Safety Manager Pharmacokineticist, PK/PD Modelling & Simulation Global Clinical Lead, Clinical Development, Migraine & Pain Director, Drug Safety Operations Medical Writer responsible for Clinical Disclosure Clinical Supply Manager You need to be a subscriber to read the rest of the article
I am not at all saying in my opinion it is the correct decision to stop the medication but please get advise before you stop
Nachnani et al (79) in a study in rats reported animals receiving exenatide for 75 days showed more acinar inflammation and pyknotic nuclei and these animals weighed less
That is to say, it may be beneficial for better application of GLP-1 drugs with a comprehensive understanding of their capacity to selectively lower BP
Concern is warranted for unlicensed operators or those making unverified efficacy claims, but established telehealth providers offer safe, regulated access to compounded therapy
A comprehensive approach focuses on restoring appropriate metabolic signaling so that improvements in weight, energy, and overall health are sustainablewhether GLP-1 medications are used temporarily, long-term, or not at all
